200 articles
What’s changing in cannabis law: our editors’ articles, and announcements straight from regulators, courts, governments and companies.
Decibel Cannabis Company Inc. has entered into a brand licensing agreement with Hilltop Leaf Ltd. to launch its cannabis flower portfolio in the United Kingdom’s medical market.
Marijuana has become Canada’s fifth-largest cash crop, generating approximately CA$3 billion in farm revenue during 2025, according to a new report released October 7 by Statistics Canada.
Of course offering extra cash this quickly into the game suggests a certain sense of desperation on the part of Boris & team
Cultivated News on the latest in this ding dong battle that’s going to be feeding the pockets of some lawyers for a while yet.
I think they used to call this Candyflipping…ok not exactly but you know what I’m driving at. Sort of thing they used to bang you up in the states for 300 years for being a menace to society.
Yep ,the nexus of the middle east Cannabis, weaponry and mioney, same as it always was.
FOR DISCUSSION ONLY Hybrid NC ABC liquor/Quebec cannabis model:
Tasmanian hemp growers are warning the state’s seed-for-food industry could be lost unless urgent action is taken to retain access to an essential weed-control treatment.
Curaleaf’s self-serving portrayal of our business is an attempt to acquire Aurora’s world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible
Exports from Canada contributed to 61% of all medical cannabis Australia imported in 2025, according to the newest figures from the country’s cannabis regulator.
Curaleaf Holdings plans to solidify its position as the global cannabis industry leader by offering to purchase all of Aurora Cannabis’ issued and outstanding common shares, the company announced Aug. 11.
, Aug. 5, 2026 /PRNewswire/ — Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in cannabis, today reported its financial and operating results…
Vancouver, Canada, July 20, 2026 (GLOBE NEWSWIRE) — Clearmind Medicine Inc. (“Clearmind”) (Nasdaq: CMND), a clinical-stage biotechnology company pioneering nonhallucinogenic neuroplastogen-derived treatments for Alcohol Use…
B) I wouldn’t like to know who the worst companies in the US are!
Optimi’s 5mg psilocybin capsules are prescribed in Australia for treatment-resistant depression. The export marks Optimi’s third commercial shipment since launching the 5mg psilocybin capsules in September 2025.
Two naturally derived finished drug products, at 1mg and 2mg, give research organizations the consistent, validated doses required for controlled studies
VANCOUVER, British Columbia, June 15, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for…
